Boehringer Ingelheim's successful drug discovery relies on excellent interdisciplinary cooperation and well-functioning medicinal chemistry with state-of-the-art tools, e.g. chemo-informatics or efficient biopharmaceutical development. The platform for our drug discovery is comprised of technologies such as e-R&D, high throughput screening (HTS) or novel biological entities.